MolNFT v1 · #178653 · protein
Structure of human beta 1,3-N-acetylglucosaminyltransferase 2 with udp and trisaccharide glcnac-BETA1-3GAL-BETA1-4GLCNAC
7JHN: “Structure of human beta 1,3-N-acetylglucosaminyltransferase 2 with udp and trisaccharide…”. X-ray diffraction, 7 ligands (UDP, NAG, MAN). MolNFT v1 #178653 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7JHN
- Type
- protein
- Length
- 327 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- Q9NY97
- Ligands
- UDP, NAG, MAN, BMA, GAL, MG, CL
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 327 | — | Q9NY97 |
Ligands and binding sites
- UDP · Uridine-5'-diphosphate · ligand · chains A
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 5 copies · chains A
- MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A
- BMA · beta-D-mannopyranose · sugar · chains A
- GAL · beta-D-galactopyranose · sugar · chains A
- MG · Magnesium ion · metal · chains A
- CL · Chloride ion · ion · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7JHN · Structure of human beta 1,3-N-acetylglucosaminyltransferase 2 with UDP and trisaccharide… · the same entry in another collection · chain A against A, TM-score 1.00
- Q9NY97 · AlphaFold monomer V2.0 prediction for N-acetyllactosaminide… · a predicted model of the same protein · chain A against A, TM-score 0.99
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9NY97
- Elsewhere: RCSB PDB 7JHN · PDBe 7JHN · UniProt Q9NY97
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.